Some sites halt using Johnson & Johnson vaccine after reports of blood clots, fainting

Several COVID-19 vaccine locations in the U.S. have stopped administering the Johnson & Johnson vaccine after people had adverse reactions.

Along with a handful of reports of blood clotting, some folks saw symptoms like nausea, dizziness and fainting.

It comes as the CDC said Johnson & Johnson has informed them that the company will allocate 86% fewer doses across the U.S. next week.

READ: J&J vaccine clinics paused in 4 states after small groups of patients have reactions; company, CDC respond

The CDC is still saying the shot is safe, but if you want the Johnson & Johnson vaccine, get it now because it could be hard to find.

The vaccine was called a game-changer, and the demand was high for the one-shot vaccine. But issues with distribution of the drug continues.

The company sent out millions of doses this week, only to now say they can’t even come close next week.

READ: COVID-19 update: Florida reports more than 7,000 new cases, 64 more deaths

The company needs the FDA approval to get production underway at a Baltimore plant where workers mixed up the ingredients with the AstraZeneca vaccine.

Florida is taking one of the biggest hits in supply. The state received 313,200 shots this week. Next week, it will get 37,000.

Sites in North Carolina and Colorado paused administering the vaccine when people fell ill during observation, and blood clot links are being investigated in Europe.

READ: Pfizer petitions FDA for approval to use COVID-19 vaccine on 12- to 15-year-old children

Federal officials said they still expect enough of the supply to meet President Joe Biden’s goal of having everyone vaccinated soon.

According to the White House, more than 112 million Americans have received at least one dose, and more than 66 million Americans are now fully vaccinated.

Shannon Butler, WFTV.com

Shannon joined the Eyewitness News team in 2013.

Adam Poulisse, WFTV.com

Adam Poulisse joined WFTV in November 2019.